Chronic hyperglycemia impairs endothelial function and insulin sensitivity via different mechanisms insulin-dependent diabetes mellitus

Circulation

Volumn 94, Issue 6, 1996, Pages 1276-1282

  Mäkimattila, Sari ^a   Virkamäki, Antti ^a   Groop, Per Henrik ^a   Cockcroft, John ^b   Utriainen, Tapio ^a   Fagerudd, Johan ^a   Yki Järvinen, Hannele ^a,c  

^a UNIVERSITY OF HELSINKI   (Finland)

^b QUEEN S MEDICAL CENTRE   (United Kingdom)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

blood flow; diabetes mellitus; endothelium derived factors; glucose; muscles

Indexed keywords

ACETYLCHOLINE; ENDOTHELIUM DERIVED CONSTRICTING FACTOR; GLYCOSYLATED HEMOGLOBIN; N(G) METHYLARGININE; NITROPRUSSIDE SODIUM;

ADULT; ARTICLE; CATHETERIZATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DISEASE ASSOCIATION; ENDOTHELIUM CELL; GLUCOSE TRANSPORT; HEMOGLOBIN ANALYSIS; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN SENSITIVITY; MALE; PRIORITY JOURNAL; RISK FACTOR; VASODILATATION;

EID: 0029819733     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.6.1276     Document Type: Article

References (34)

1. Stehouwer CD, Nauta JJP, Zeldenrust GC, Hackeng WHL, Donker AJM, den Ottolander GJH. Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus. Lancet. 1992;340:319-323.
2. Chowienczyk PJ, Watts GF, Cockcroft JR, Ritter JM. Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolaemia. Lancet, 1992;340:1430-1432.
3. Kuusisto J, Mykkänen L, Pyörälä K, Laakso M. NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes. 1995;43:960-967.
4. Tesfamariam B, Brown ML, Deykin D, Cohen R. Elevated glucose promotes generation of endothelium-derived vasoconstrictor prostanoids in rabbit aorta. J Clin Invest. 1990;85:929-932.
5. Durante W, Sen AK, Sunahara FA. Impairment of endothelium-dependent relaxation in aortae from spontaneously diabetic rats. Br J Pharmacol. 1988;94:463-468.
6. Meraji S, Jayakody L, Senaratne MP. Thomson ABR, Kappagoda T. Endothelium-dependent relaxation in aorta from diabetic rats. Diabetes. 1987;36:978-981.
7. deTejada IS, Goldstein I, Azadzoi K, Krane RJ, Cohen RA. Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. N Engl J Med. 1989;320:1025-1030.
8. Elliot TG, Cockcroft JR, Groop P-H, Viberti GC, Ritter JM. Inhibition of nitric oxide synthesis in forearm vasculature of insulin dependent diabetic patients: blunted vasoconstriction in patients with microalburninuria. Clin Sci. 1993;85:687-693.
9. Calver A, Collier J, Vallance P. Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J Clin Invest. 1992;90:2548-2554.
10. Smits P, Kapma J-A, Jacobs M-C, Lutterman J, Tien T. Endothelium-dependent vascular relaxation in patients with type 1 diabetes. Diabetes. 1993;42:148-153.
11. Johnstone MT, Craeger SJ, Scales KM, Cusco JA, Lee BK, Craeger MA. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation. 1993;88:2510-2516.
12. McNally PG, Watt PAC, Rimmer T, Burden AC, Hearnshow JR, Thurston H. Impaired contraction and endothelium-dependent relaxation in isolated resistance vessels from patients with insulin-dependent diabetes mellitus. Clin Sci. 1994;87:31-36.
13. Yip J, Mattock MB, Morocutti A, Sethi M, Trevisan R, Viberti G. Insulin resistance in insulin-dependent diabetic patients with microalburninuria. Lancet. 1993;342:883-887.
14. Scherrer U, Randin D, Vollenweider P, Vollenweider L, Nicod P. Nitric oxide release accounts for insulin's vascular effects in humans. J Clin Invest. 1994;94:2511-2515.
15. Rees DD, Palmer RMJ, Hodson HF, Moncada S. A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent dilatation. Br J Pharmacol. 1989;996:418-424.
16. Yki-Järvinen H, Sahlin K, Ren JM, Koivisto VA. Localization of the rate-limiting defect for glucose disposal in skeletal muscle of insulin-resistant type 1 diabetic patients. Diabetes. 1990;39:157-167.
17. Vuorinen-Markkola H, Koivisto VA, Yki-Järvinen H. Mechanisms of hyperglycemia-induced insulin resistance in whole body and skeletal muscle of type 1 diabetic patients. Diabetes. 1992;41:571-580.
18. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237:E214-E223.
19. Yki-Järvinen H, Young AA, Lamkin C, Foley JE. Kinetics of glucose disposal in whole body and across the forearm in man. J Clin Invest. 1987;79:1713-1719.
20. Yki-Järvinen H, Koivisto VA. Natural course of insulin resistance in type 1 diabetes. N Engl J Med. 1986;315:224-230.
21. Utriainen T, Malmström R, Mäkimattila S, Yki-Järvinen H. Methodological aspects, dose-response characteristics and causes of inter-individual variation in insulin stimulation of limb blood flow in normal subjects. Diabetologia. 1995;38:555-564.
22. Rising R, Swinburn B, Larson K, Ravussin E. Body composition in Pima Indians: validation of bioelectrical resistance. Am J Clin Nutr. 1991;53:594-598.
23. Kersten JR, Brooks LA, Dellsperger KC. Impaired microvascular response to graded coronary occlusion in diabetic and hyperglycemic dogs. Am J Physiol. 1995;268:H1667-H1674.
24. Halkin A, Benjamin N, Doktor HS, Todd SD, Viberti GC, Ritter JM. Vascular responsiveness and cation exchange in insulin-dependent diabetes. Clin Sci. 1991;81:223-232.
25. Chowienczyk PJ, Watts GF, Brett SE, Ritter JM. Sex differences in endothelial function in normal and hypercholesterolemic subjects. Lancet. 1994;344:305-306.
26. Decken T, Kofoed-Enevoldsen A, Norgaard K, Borch-Johnsen K, Feldt-Rasmussen B, Jensen T. Microalbuminuria: implications for micro- and macrovascular disease. Diabetes Care. 1992;15:1181-1191.
27. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.
28. Nielsen S, Schmitz A, Poulsen PL, Hansen KW, Mogensen CE. AI-buminuria and 24-h ambulatory blood pressure in normoalbuminuric and microalbuminuric NIDDM patients. Diabetes Care. 1995;11:1434-1441.
29. Natali A, Santoro D, Palombo C, Cerri M, Ghione M, Ferrannini E. Impaired insulin action on skeletal muscle metabolism in essential hypertension. Hypertension. 1991;17:170-178.
30. Smits P, Hersbach F, Jansen T, Tien T, Lutterman J. Impaired vasodilator response to atrial natriuretic factor in IDDM. Diabetes. 1993;42:1454-1461.
31. Rosen P, Ballhausen T, Stockklauser K, Hönack C. Influence of glucose and diabetes on the endothelial NO-synthase. Diabetologia. 1995;38:A48. Abstract.
32. Baron AD, Laakso M, Brechtel G, Edelman SV. Mechanism of insulin resistance in insulin-dependent diabetes mellitus: a major role for reduced skeletal muscle blood flow. J Clin Endocrinol Metab. 1991;73:637-643.
33. Yki-Järvinen H, Daniels MC, Virkamäki A, Mäkimattila S, DeFronzo RA, McCain D. Increased glutamine: fructose-6-phosphate amido-transferase activity in skeletal muscle of patients with NDDM, Diabetes. 1996;45:302-307.
34. Marshall S, Bacote V, Traxinger RR. Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system: role of hexosamine biosynthesis in the induction of insulin resistance. J Biol Chem. 1991;266:4706-4712.